Daily SPAC Update – Jan 22, 2024

by | Jan 22, 2024

Daily SPAC Update for Jan 22, 2024. A Quiet start to the SPAC week. Extension votes this week include DMAQ, JWSM, CSTAF.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha SPAC Intelligence Platform (7-Day Trial)

OTHER SPAC NEWS
CSTAF – CONSTELLATION ACQUISITION CORP IPreliminary update on redemptions prior to Jan 23 extension vote * 3,399,900 redeemed
ACAB – ATLANTIC COASTAL ACQUISITION CORP IIReleased SPAC Investor Deck for its deal with Abpro

EXTENSION VOTE SET
CVII – CHURCHILL CAPITAL CORP VII * Extension Vote Set: Feb 08, 2024 * trust $10.54

SEPARATE WARRANTS/RIGHTS
AFJK on Jan 22

THIS WEEK’S EXTENSION VOTES
CSTAF – CONSTELLATION ACQUISITION CORP I * Vote Jan 23, 2024 -> 12 monthly extensions to Jan 29, 2025
DMAQ – DEEP MEDICINE ACQUISITION CORP * vote Jan 26, 204 -> extend to July 29, 2024
JWSM – JAWS MUSTANG ACQUISITION CORP * vote Jan 25, 2024 -> extend to Feb 4, 2025

YESTERDAY’S TOP SPAC GAINERS
18.40% ~ $ 5.02 | ATAK – Aurora Technology Acquisition Corp. (Announced)
5.90% ~ $ 11.12 | APAC – StoneBridge Acquisition Corp. (Announced)
4.04% ~ $ 11.37 | OTEC – OceanTech Acquisitions I Corp. (Announced)
3.44% ~ $ 20.12 | MCAF – Mountain Crest Acquisition Corp. IV (Announced)
3.31% ~ $ 11.25 | ASCB – A SPAC II Acquisition Corp. (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-14.96% ~ $ 6.65 | NCAC – Newcourt Acquisition Corp (Announced)
-7.46% ~ $ 6.70 | NUBI – Nubia Brand International Corp. (Announced)
-3.18% ~ $ 10.65 | FICV – Frontier Investment Corp (Pre-Deal)
-2.44% ~ $ 8.00 | DMAQ – Deep Medicine Acquisition Corp. (Announced)
-2.43% ~ $ 11.03 | TWLV – Twelve Seas Investment Company II (Pre-Deal)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.